Aethlon Medical (AEMD) Long-Term Deferred Tax (2015 - 2026)

Aethlon Medical's Long-Term Deferred Tax history runs 12 years deep, the most recent figure standing at $36.6 million for Q1 2026.

• Quarterly Long-Term Deferred Tax rose 6.54% year-over-year to $36.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.6 million (up 6.54% YoY) and the FY2026 annual result came in at $36.6 million, up 6.54% from the prior year.
• Long-Term Deferred Tax was $36.6 million for Q1 2026 at Aethlon Medical, up from $34.4 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $36.6 million in Q1 2026 and bottomed at $27.1 million in Q1 2022.
• A 5-year average of $32.3 million and a median of $33.3 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2023 — Long-Term Deferred Tax climbed 10.82% — and 2025, when it rose 3.42%.
• Aethlon Medical's Long-Term Deferred Tax stood at $27.1 million in 2022, then grew by 10.82% to $30.0 million in 2023, then grew by 10.78% to $33.3 million in 2024, then increased by 3.42% to $34.4 million in 2025, then rose by 6.54% to $36.6 million in 2026.
• Business Quant data shows AEMD's Long-Term Deferred Tax at $36.6 million in Q1 2026, $34.4 million in Q1 2025, and $33.3 million in Q1 2024.